Covered recipient · General Payments record
WOOJIN JOO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$4,448.59
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $636.43 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $223.76 | 10 |
| ABBVIE INC. | $159.83 | 6 |
| Novo Nordisk AS | $90.72 | 4 |
| PFIZER INC. | $63.24 | 2 |
| DEXCOM, INC. | $34.12 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $25.31 | 1 |
| Amgen Inc. | $20.31 | 1 |
| Acerta Pharma LLC | $19.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010766 | CMS |
| ABBVIE INC. | $13.62 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010768 | CMS |
| ABBVIE INC. | $29.70 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010770 | CMS |
| ABBVIE INC. | $29.56 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010772 | CMS |
| ABBVIE INC. | $29.28 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010774 | CMS |
| ABBVIE INC. | $29.56 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010776 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $25.31 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147019188 | CMS |
| Amgen Inc. | $20.31 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773499 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.14 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105608469 | CMS |
| Dexcom, Inc. | $34.12 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153344659 | CMS |
| Lilly USA, LLC | $31.64 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135501916 | CMS |
| Lilly USA, LLC | $22.40 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135501918 | CMS |
| Lilly USA, LLC | $26.44 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474082 | CMS |
| Lilly USA, LLC | $25.28 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135517836 | CMS |
| Lilly USA, LLC | $29.21 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135482631 | CMS |
| Lilly USA, LLC | $19.49 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135482633 | CMS |
| Lilly USA, LLC | $18.31 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135517838 | CMS |
| Lilly USA, LLC | $2.83 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135442525 | CMS |
| Lilly USA, LLC | $20.38 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508512 | CMS |
| Lilly USA, LLC | $27.78 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135501920 | CMS |
| Novo Nordisk Inc | $17.45 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097709135 | CMS |
| Novo Nordisk Inc | $15.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096819177 | CMS |
| Novo Nordisk Inc | $22.67 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097682942 | CMS |
| Novo Nordisk Inc | $35.60 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937149 | CMS |
| PFIZER INC. | $37.22 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131955836 | CMS |
| PFIZER INC. | $26.02 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131193930 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.